Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short term Debt (2018 - 2020)

AC Immune has reported Short term Debt over the past 3 years, most recently at $336773.3 for Q3 2020.

  • Quarterly Short term Debt fell 0.66% to $336773.3 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $336773.3 through Sep 2020, down 0.66% year-over-year, with the annual reading at $656409.3 for FY2019, 96.76% up from the prior year.
  • Short term Debt was $336773.3 for Q3 2020 at AC Immune, up from $333137.6 in the prior quarter.
  • Over five years, Short term Debt peaked at $658770.1 in Q4 2019 and troughed at $328.11 in Q2 2019.
  • The 3-year median for Short term Debt is $335869.8 (2020), against an average of $334242.4.
  • The largest YoY upside for Short term Debt was 101430.97% in 2020 against a maximum downside of 0.71% in 2020.
  • A 3-year view of Short term Debt shows it stood at $333605.1 in 2018, then skyrocketed by 97.47% to $658770.1 in 2019, then plummeted by 48.88% to $336773.3 in 2020.
  • Per Business Quant, the three most recent readings for ACIU's Short term Debt are $336773.3 (Q3 2020), $333137.6 (Q2 2020), and $334966.3 (Q1 2020).